TransMedics Group (HAM:8T8) Moat Score: 6/10 (As of Jun. 30, 2026)


HAM:8T8 TransMedics Group Inc HAM:8T8
69 GF Score
Price €60.02
GF Value €162.08
! 9 Warning Signs
View Full Analysis

What is TransMedics Group Moat Score?

TransMedics Group HAM:8T8 -9.99% 69 Moat Score is 6 as of Jun. 30, 2026. GuruFocus rates HAM:8T8 with a GF Score™ of 69/100 and a GF Value™ of €162.08. The stock has 9 warning signs investors should review. Among 846 Medical Devices & Instruments companies, TransMedics Group ranks better than 95.74% on this metric.

TransMedics Group has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

TransMedics Group has Narrow Moat: TransMedics Group Inc has a strong narrow moat due to its innovative organ transplant technology and significant R&D capabilities. The company benefits from high customer switching costs and some regulatory barriers, but lacks the scale and brand strength to be considered a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes TransMedics Group might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

TransMedics Group  (HAM:8T8) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

TransMedics Group Moat Score Related Terms

HAM:8T8 vs AXGN, BFLY, ESTA: Moat Score Comparison

For the Medical Devices subindustry, TransMedics Group's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TransMedics Group Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, TransMedics Group's Moat Score distribution charts can be found below:

* The bar in red indicates where TransMedics Group's Moat Score falls into.


HAM:8T8
69GF Score
TransMedics Group Inc HAM:8T8
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 6 mean?
TransMedics Group (HAM:8T8) has a Moat Score of 6 as of Jun. 30, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, TransMedics Group ranks #36 out of 846 companies in the Medical Devices & Instruments industry, placing it in the top 4.3%.
Is TransMedics Group's Moat Score too high?
TransMedics Group's current Moat Score is 6. Based on the distribution chart, TransMedics Group ranks #36 out of 846 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, TransMedics Group has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does TransMedics Group's Moat Score compare to AXGN and BFLY?
According to the Medical Devices & Instruments industry distribution chart, TransMedics Group ranks #36 out of 846 companies for Moat Score. This places TransMedics Group in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. TransMedics Group's current Moat Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TransMedics Group stock overvalued right now?
TransMedics Group (HAM:8T8) has a current Moat Score of 6. The stock's GF Value™ is €162.08, compared to a current price of €60.02 — trading 63% below its estimated fair value. The current Moat Score is 6. TransMedics Group's overall GF Score™ is 69/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For TransMedics Group (HAM:8T8), the current Moat Score is 6 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TransMedics Group (HAM:8T8) Overvalued in 2026?

Based on GuruFocus' analysis, TransMedics Group stock appears to be undervalued. The current stock price of €60.02 is trading 63% below its estimated GF Value™ of €162.08.

Key valuation signals for HAM:8T8:

  • Moat Score: 6
  • GF Value™: €162.08 vs. price of €60.02 (63% below fair value)
  • GF Score™: 69/100 with 9 warning signs

No single metric tells the full story. See the HAM:8T8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TransMedics Group Business Description

Address 200 Minuteman Road, Andover, MA, USA, 01810
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
69GF Score

Get the complete analysis for HAM:8T8

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€60.02
Price
€162.08
GF Value